Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE3
The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）
- Status
- UNKNOWN
- Phase
- PHASE3
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
- Status
- COMPLETED
- Phase
- PHASE3
MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2